Takara Bio Inc.

TSE:4974.T

1005 (JPY) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q2
Revenue 8,49313,77110,6189,9409,17617,93627,61918,48514,10222,04014,10816,27915,27216,53712,15610,4556,93810,0078,1087,8008,6509,9538,5188,5238,8479,6668,5207,7716,3558,7307,4466,8936,3069,0237,4497,4965,7618,6766,3226,1924,7797,7385,8906,1074,1706,6484,9034,9094,1046,1354,8014,8193,8235,7024,5924,6713,7725,7624,8724,8383,8525,4944,4924,941
Cost of Revenue 4,1394,9055,9203,0892,6839,60613,2096,5853,9776,9293,5035,9232,1335,9172,7323,3312,2343,6923,6463,3872,7344,2083,8983,5583,4913,7783,9143,7202,2454,3162,9542,7132,4394,2063,2953,4652,4394,3032,9232,8922,0243,8312,8272,6961,9773,2652,3142,3921,5693,1282,1932,1901,6832,7682,1302,3521,6072,8992,2762,3141,7962,6711,9932,534
Gross Profit 4,3548,8664,6986,8516,4938,33014,41011,90010,12515,11110,60510,35613,13910,6209,4247,1244,7046,3154,4624,4135,9165,7454,6204,9655,3565,8884,6064,0514,1104,4144,4924,1803,8674,8174,1544,0313,3224,3733,3993,3002,7553,9073,0633,4112,1933,3832,5892,5172,5353,0072,6082,6292,1402,9342,4622,3192,1652,8632,5962,5242,0562,8232,4992,407
Gross Profit Ratio 0.5130.6440.4420.6890.7080.4640.5220.6440.7180.6860.7520.6360.860.6420.7750.6810.6780.6310.550.5660.6840.5770.5420.5830.6050.6090.5410.5210.6470.5060.6030.6060.6130.5340.5580.5380.5770.5040.5380.5330.5760.5050.520.5590.5260.5090.5280.5130.6180.490.5430.5460.560.5150.5360.4960.5740.4970.5330.5220.5340.5140.5560.487
Reseach & Development Expenses 1,7062,2051,8782,0012,2402,7082,0141,9941,8592,0891,3611,3651,2941,8891,2531,2311,1721,0579549199391,1731,0601,0901,0141,2361,1201,1941,1031,2319669549501,1571,0351,0631,0201,1768236997038727477037047226836646467626386506088735796445951,042750751751807738747
General & Administrative Expenses 0000000000000000000002,0880002,0970002,0250001,65400000001,175000844000000000000000000
Selling & Marketing Expenses 0000000000000000000007030007290008540009710000000985000963000000000000000000
SG&A 4,0253,9963,9333,7163,6114,4853,8883,4063,4624,4113,5103,1313,1483,8583,1032,7092,6873,0862,7072,5832,5852,7912,7772,6512,6652,8262,6372,3762,6072,8792,1902,3922,1872,6252,3412,3072,1072,3081,9491,9611,9052,1601,8371,8191,7771,8071,6311,5320000000000000000
Other Expenses -2577327212241313933566422245627122125312123446962216558127227631410337346134304913131561689158139919411681091145130388261929
Operating Expenses 5,9886,2015,7705,8646,0677,1905,8775,5675,5856,1364,7834,7574,6315,4594,3704,0814,0073,9173,6183,6293,6633,7133,8093,8883,8083,9403,6873,6253,8443,9373,1443,4473,2203,5923,3933,4593,2083,3352,7602,7412,6862,8592,6112,5972,5492,3974,5141,2091,2072,2051,1381,1411,1282,2811,1031,1661,1522,4951,2591,2721,2602,4441,2691,269
Operating Income -1,6342,665-1,0749874231,1388,5336,3334,5378,9765,8215,6018,5045,1615,0553,0436932,3958447842,2512,0318091,0791,5441,9479204262624781,3477346431,2237605731111,039638560651,046454812-358984-1,9261,3081,3288021,4701,4881,0126531,3591,1531,0133681,3371,2527963791,2301,138
Operating Income Ratio -0.1920.194-0.1010.0990.0460.0630.3090.3430.3220.4070.4130.3440.5570.3120.4160.2910.10.2390.1040.1010.260.2040.0950.1270.1750.2010.1080.0550.0410.0550.1810.1060.1020.1360.1020.0760.0190.120.1010.090.0140.1350.0770.133-0.0860.148-0.3930.2660.3240.1310.3060.3090.2650.1150.2960.2470.2690.0640.2740.2590.2070.0690.2740.23
Total Other Income Expenses Net 127-312-149680-232-4619938-1,5599242543124-49840-84789-25-6288-543-1901-330744513-297-1564868616897332-213342317938-37471652,600-1,043-1,15150-961-1,164-1,03524-1,066-1,022-1,136-10-1,076-1,008-962-117-1,081-1,275
Income Before Tax -1,5072,353-1,0881,0835059068,4876,3525,4797,4185,9115,6428,5615,1935,0782,5457361,5509337592,1912,1202678881,5481,6199934712781801,1927816521,2328226402111,371426593911,228490777-3101,152674265177852509324-23677293131-123358261244-166262149-137
Income Before Tax Ratio -0.1770.171-0.1020.1090.0550.0510.3070.3440.3890.3370.4190.3470.5610.3140.4180.2430.1060.1550.1150.0970.2530.2130.0310.1040.1750.1670.1170.0610.0440.0210.160.1130.1030.1370.110.0850.0370.1580.0670.0960.0190.1590.0830.127-0.0740.1730.1370.0540.0430.1390.1060.067-0.0060.1190.0640.028-0.0330.0620.0540.05-0.0430.0480.033-0.028
Income Tax Expense -4751,020-166317172-5082,4251,7171,5421,9281,5481,6312,5171,3611,620664326436295275595537-10620451434922419725337829940436851035345724531591621575306176296-52405275597032622776211610630108452283-44-66210722
Net Income -1,0471,326-9307653191,4176,0574,6313,9075,4854,3553,9846,0253,8213,4521,8704041,1116334841,5911,5693686881,0321,26776628022-209894382285721468181-361,047-48838618928315481-254749399209105525275249-26558181100-234314238161-12292641-160
Net Income Ratio -0.1230.096-0.0880.0770.0350.0790.2190.2510.2770.2490.3090.2450.3950.2310.2840.1790.0580.1110.0780.0620.1840.1580.0430.0810.1170.1310.090.0360.003-0.0240.120.0550.0450.080.0630.024-0.0060.121-0.0770.0620.0040.120.0530.079-0.0610.1130.0810.0430.0260.0860.0570.052-0.0070.0980.0390.021-0.0620.0540.0490.033-0.0320.1690.009-0.032
EPS -8.6911.01-7.726.352.6511.7750.338.4632.4545.5536.1733.0850.0431.7328.6715.533.369.235.264.0213.2213.033.065.718.5710.526.362.330.19-1.747.423.172.375.993.891.5-0.38.69-4.053.210.157.712.624.23-2.236.593.511.850.934.652.442.21-0.234.941.60.89-2.072.782.111.43-1.088.210.36-1.42
EPS Diluted -8.6911.01-7.726.352.6511.7750.338.4632.4545.5536.1733.0850.0431.7328.6715.533.369.235.264.0213.2213.033.065.718.5710.526.362.330.19-1.747.423.172.375.993.891.5-0.38.69-4.053.210.157.712.624.23-2.236.593.511.850.934.652.442.21-0.234.941.60.89-2.072.782.111.43-1.088.210.36-1.42
EBITDA -4963,8813072,3631,7372,4699,7287,5175,7279,4117,0056,6789,5356,1836,0364,0401,7093,4221,7461,6293,0822,8972,2642,1252,3972,9521,8211,3121,0131,2391,9231,2961,1712,1401,3731,1527041,8801,1321,0014421,6328741,151571,531-1,4841,7271,7081,3791,8961,9001,4271,2021,7831,6081,4301,0121,7901,7571,3608361,7291,130
EBITDA Ratio -0.0580.2820.0290.2380.1890.1380.3520.4070.4060.4270.4970.410.6240.3740.4970.3860.2460.3420.2150.2090.3560.2910.2660.2490.2710.3050.2140.1690.1590.1420.2580.1880.1860.2370.1840.1540.1220.2170.1790.1620.0920.2110.1480.1880.0140.23-0.3030.3520.4160.2250.3950.3940.3730.2110.3880.3440.3790.1760.3670.3630.3530.1520.3850.229